(Q34707196)

4 August 2017

title

What is the best maintenance dose of neuroleptics in schizophrenia? (English)

1 reference

4 August 2017

0 references

R. J. Baldessarini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118906

8 August 2023

J. M. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6118906

8 August 2023

language of work or name

English

0 references

publication date

1 October 1980

1 reference

full work available at URL

4 August 2017

https://api.elsevier.com/content/article/PII:0165178180900281?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

https://api.elsevier.com/content/article/PII:0165178180900281?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

8 August 2023

1 reference

4 August 2017

volume

3

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

115-122

1 reference

A controlled trial of phenothiazine withdrawal in chronic schizophrenic patients

4 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Behavioral effects of interrupting and resuming tranquilizing medication among schizophrenics

8 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS

8 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Overview: maintenance therapy in psychiatry: I. Schizophrenia

8 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Comparative Doses and Costs of Antipsychotic Medication

8 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Discontinuance of tranquilizers among chronic schizophrenic patients receiving maintenance dosage

8 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Phenothiazines in prevention of psychiatric hospitalization. IV. Delay or prevention of hospitalization--a reevaluation

8 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Withdrawal of ataractic medication in schizophrenic patients

8 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Persistence of Extra-pyramidal Disorders and Psychiatric Relapse after Withdrawal of Long-Term Phenothiazine Therapy

8 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry.

8 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Drug and sociotherapy in the aftercare of schizophrenic patients. One-year relapse rates

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates

8 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Low dose fluphenazine decanoate in maintenance treatment of schizophrenia

8 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Trial of Maintenance Therapy in Schizophrenia

8 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research

8 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Relapse in chronic schizophrenics following abrupt withdrawal of tranquillizing medication

8 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

High Dose Trifluoperazine Therapy in Chronic Schizophrenia

8 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year

8 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Comparison of chlorpromazine and reserpine in maintenance drug therapy

8 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Tardive dyskinesia and psychotropic drug history

8 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

Withdrawal of perphenazine in chronic schizophrenia

8 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

A comparison of equivalent clinical potencies of neuroleptics as used to treat schizophrenia and affective disorders

8 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0165-1781(80)90028-1

8 August 2023

Identifiers

1 reference

release_x5u3wi32nzhd7l3jwa5lcp3ngi

4 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x5u3wi32nzhd7l3jwa5lcp3ngi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference